<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Icon Plc — News on 6ix</title>
<link>https://6ix.com/company/icon-plc</link>
<description>Latest news and press releases for Icon Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 11:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/icon-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835818f78dffbe2df0fbe61.webp</url>
<title>Icon Plc</title>
<link>https://6ix.com/company/icon-plc</link>
</image>
<item>
<title>ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/icon-plc/news/icon-provides-update-on-audit-committee-investigation-and-timing-of-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-provides-update-on-audit-committee-investigation-and-timing-of-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Wed, 29 Apr 2026 11:00:00 GMT</pubDate>
<description>DUBLIN, April 29, 2026--ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results</description>
</item>
<item>
<title>ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model</title>
<link>https://6ix.com/company/icon-plc/news/icon-and-advarra-introduce-new-research-ready-connected-site-network-model</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-and-advarra-introduce-new-research-ready-connected-site-network-model</guid>
<pubDate>Tue, 24 Mar 2026 04:00:00 GMT</pubDate>
<description>Partnership will integrate ICON’s clinical trial technology with Advarra’s purpose-built system for research sites, embedded across a broad, deeply</description>
</item>
<item>
<title>ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices</title>
<link>https://6ix.com/company/icon-plc/news/icon-plc-provides-timing-fourth-110000107</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-plc-provides-timing-fourth-110000107</guid>
<pubDate>Thu, 12 Feb 2026 11:00:00 GMT</pubDate>
<description>DUBLIN, February 12, 2026--ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices</description>
</item>
<item>
<title>ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership</title>
<link>https://6ix.com/company/icon-plc/news/icon-accellacare-network-expands-oncology-121500374</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-accellacare-network-expands-oncology-121500374</guid>
<pubDate>Tue, 27 Jan 2026 12:15:00 GMT</pubDate>
<description>DUBLIN, January 27, 2026--ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly Health and Care in Illinois.</description>
</item>
<item>
<title>ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive</title>
<link>https://6ix.com/company/icon-plc/news/icon-2025-global-biotech-survey-solidifies-china-dominance-and-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-2025-global-biotech-survey-solidifies-china-dominance-and-highlights</guid>
<pubDate>Tue, 09 Dec 2025 05:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys.</description>
</item>
<item>
<title>ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions</title>
<link>https://6ix.com/company/icon-plc/news/icon-survey-reveals-increasing-clinical-trial-startup-delays-underscoring-need-human</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-survey-reveals-increasing-clinical-trial-startup-delays-underscoring-need-human</guid>
<pubDate>Tue, 02 Dec 2025 05:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey,</description>
</item>
<item>
<title>ICON plc to Present at the Jefferies London Healthcare Conference</title>
<link>https://6ix.com/company/icon-plc/news/icon-plc-present-jefferies-london-healthcare-conference-2025-11-12</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-plc-present-jefferies-london-healthcare-conference-2025-11-12</guid>
<pubDate>Wed, 12 Nov 2025 05:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that Mr. Barry Balfe, CEO of ICON plc and</description>
</item>
<item>
<title>ICON Reports Third Quarter 2025 Results</title>
<link>https://6ix.com/company/icon-plc/news/icon-reports-third-quarter-2025-results-2025-10-22</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-reports-third-quarter-2025-results-2025-10-22</guid>
<pubDate>Wed, 22 Oct 2025 04:00:00 GMT</pubDate>
<description>Highlights Quarter three revenue was $2,042.8 million representing an increase of 1.3% on quarter two 2025. Net income for the quarter was $2.4 million or</description>
</item>
<item>
<title>ICON plc Schedules Third Quarter 2025 Earnings Conference Call</title>
<link>https://6ix.com/company/icon-plc/news/icon-plc-schedules-third-quarter-2025-earnings-conference-call-2025-09-24</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-plc-schedules-third-quarter-2025-earnings-conference-call-2025-09-24</guid>
<pubDate>Wed, 24 Sep 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that it will release its financial results</description>
</item>
<item>
<title>ICON Announces CEO Transition</title>
<link>https://6ix.com/company/icon-plc/news/icon-announces-ceo-transition-2025-09-04</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-announces-ceo-transition-2025-09-04</guid>
<pubDate>Thu, 04 Sep 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the</description>
</item>
<item>
<title>ICON plc to Participate at Upcoming Investor Conferences</title>
<link>https://6ix.com/company/icon-plc/news/icon-plc-participate-upcoming-investor-conferences-2025-09-02</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-plc-participate-upcoming-investor-conferences-2025-09-02</guid>
<pubDate>Tue, 02 Sep 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that</description>
</item>
<item>
<title>ICON Announces Results of Annual General Meeting</title>
<link>https://6ix.com/company/icon-plc/news/icon-announces-results-annual-general-meeting-2025-07-23</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-announces-results-annual-general-meeting-2025-07-23</guid>
<pubDate>Wed, 23 Jul 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation powered by healthcare intelligence, today announced that</description>
</item>
<item>
<title>ICON Reports Second Quarter 2025 Results</title>
<link>https://6ix.com/company/icon-plc/news/icon-reports-second-quarter-2025-results-2025-07-23</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-reports-second-quarter-2025-results-2025-07-23</guid>
<pubDate>Wed, 23 Jul 2025 04:00:00 GMT</pubDate>
<description>Highlights Gross business wins in the quarter of $2,966 million, representing an increase of 10.6% on quarter one 2025. Net business wins in the quarter of</description>
</item>
<item>
<title>ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report</title>
<link>https://6ix.com/company/icon-plc/news/icons-leadership-and-performance-phase-1-clinical-trials-recognised-independent</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icons-leadership-and-performance-phase-1-clinical-trials-recognised-independent</guid>
<pubDate>Wed, 16 Jul 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the</description>
</item>
<item>
<title>ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability</title>
<link>https://6ix.com/company/icon-plc/news/icon-and-its-employees-recognised-clinical-research-industry-leaders-and-innovation</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-and-its-employees-recognised-clinical-research-industry-leaders-and-innovation</guid>
<pubDate>Mon, 07 Jul 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first</description>
</item>
<item>
<title>ICON plc Schedules Second Quarter 2025 Earnings Conference Call</title>
<link>https://6ix.com/company/icon-plc/news/icon-plc-schedules-second-quarter-2025-earnings-conference-call-2025-06-23</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-plc-schedules-second-quarter-2025-earnings-conference-call-2025-06-23</guid>
<pubDate>Mon, 23 Jun 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it</description>
</item>
<item>
<title>ICON plc to Present at the William Blair 45th Annual Growth Stock Conference</title>
<link>https://6ix.com/company/icon-plc/news/icon-plc-present-william-blair-45th-annual-growth-stock-conference-2025-05-27</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-plc-present-william-blair-45th-annual-growth-stock-conference-2025-05-27</guid>
<pubDate>Tue, 27 May 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that</description>
</item>
<item>
<title>ICON releases its ICON Cares 2024 Report</title>
<link>https://6ix.com/company/icon-plc/news/icon-releases-its-icon-cares-2024-report-2025-05-19</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-releases-its-icon-cares-2024-report-2025-05-19</guid>
<pubDate>Mon, 19 May 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON</description>
</item>
<item>
<title>Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies</title>
<link>https://6ix.com/company/icon-plc/news/global-icon-survey-shows-need-more-efficient-obesity-clinical-trial-design-realise</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/global-icon-survey-shows-need-more-efficient-obesity-clinical-trial-design-realise</guid>
<pubDate>Wed, 07 May 2025 04:00:00 GMT</pubDate>
<description>DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the</description>
</item>
<item>
<title>ICON Reports First Quarter 2025 Results</title>
<link>https://6ix.com/company/icon-plc/news/icon-reports-first-quarter-2025-results-2025-04-30</link>
<guid isPermaLink="true">https://6ix.com/company/icon-plc/news/icon-reports-first-quarter-2025-results-2025-04-30</guid>
<pubDate>Wed, 30 Apr 2025 04:00:00 GMT</pubDate>
<description>Highlights Net business wins in the quarter of $2,022 million; a net book to bill in the quarter of 1.01. Closing backlog of $24.7 billion, an increase of</description>
</item>
</channel>
</rss>